- Published at
- by thestreet.com
neutral
neutral
Antibe Therapeutics Virtually Opens The Market
TORONTO, Feb. 8, 2021 /CNW/ - Dan Legault, Chief Executive Officer and Director, Antibe Therapeutics Inc. (TSX: ATE), and his team joined Dani Lipkin,
News for Antibe Therapeutics Inc. (4B70.F)
- Published at
- by thestreet.com
neutralneutralAntibe Therapeutics Strengthens Partnering Advisory Team With Appointment Of Don Haut
Antibe Therapeutics Inc. (TSX: ATE, OTCQB: ATBPF), a clinical stage company leveraging its unique hydrogen sulfide platform to develop safer medicines for pain